Intellect Neurosciences Inc. (fka ILNS)

[itwillgetbetter]

I hope you right cause you seem to have knowledge regarding these trials and I'm learning but still don't understand how to yet.

Pfizer or Shire could buy this for pocket change to them. I don't see what the hold up is on the SHP-622 data being published.

Ponezumab is years out imo to complete phase III if they go it. It be like 2018 so the money if any will come from Shire regarding a milestone again imo.

Maybe one day in 2016 we get a update as promised but I'm not betting on that from the company.

I say this the odds the last patient regarding the F/A trial was given a blank is so high it be almost impossible imo cause they delayed it for months to fill that one slot so I doubt that occurred.